Binder phenotype: Clinical and etiological heterogeneity of the so-called Binder maxillonasal dysplasia in prenatally diagnosed cases, and review of the literature

Prenatal Diagnosis

Volumn 29, Issue 2, 2009, Pages 140-150

  Levaillant, J M ^a   Moeglin, D ^b   Zouiten, K ^c   Bucourt, M ^d   Burglen, L ^e   Soupre, V ^e,f   Baumann, C ^g   Jaquemont, M L ^g   Touraine, R ^h   Picard, A ^e,f   Vuillard, E ^g   Belarbi, N ^g   Oury, J F ^g   Verloes, A ^g   Vazquez, M P ^e,f   Labrune, P ⁱ   Delezoide, A L ^g   Gerard Blanluet, M ^g  

^a HÔPITAL ANTOINE BÉCLÈRE   (France)

^b Fetal Imaging   (France)

^c Fetal Imaging   (France)

^d HÔPITAL JEAN VERDIER   (France)

^e ARMAND TROUSSEAU HOSPITAL   (France)

^f SORBONNE UNIVERSITÉ   (France)

^g HÔPITAL ROBERT DEBRÉ   (France)

^h HÔPITAL NORD   (France)

ⁱ ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

Author keywords

Binder syndrome; Chondrodysplasia punctata; Fetal dysmorphology; Nasal bones; Spina nasalis; Ultrasonography

Indexed keywords

ARTICLE; BINDER PHENOTYPE; CHONDRODYSPLASIA PUNCTATA; CLINICAL ARTICLE; CONTROLLED STUDY; FACE MALFORMATION; FEMALE; FETUS; FETUS ECHOGRAPHY; HUMAN; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PHENOTYPE; PRENATAL DIAGNOSIS; PRIORITY JOURNAL;

CHONDRODYSPLASIA PUNCTATA; FEMALE; HUMANS; INFANT, NEWBORN; MALE; MAXILLOFACIAL ABNORMALITIES; PHENOTYPE; PREGNANCY; RETROSPECTIVE STUDIES; ULTRASONOGRAPHY, PRENATAL;

NASALIS;

EID: 59649101167     PISSN: 01973851     EISSN: 10970223     Source Type: Journal    
DOI: 10.1002/pd.2167     Document Type: Article

References (42)

1. Austin-Ward E, Castillo S, Cuchacovich M, et al. 1998. Neonatal lupus syndrome: a case with chondrodysplasia punctata and other unusual manifestations. J Med Genet 35(8): 695-697.
2. Becker MH, Genieser NB, Finegold M, Miranda D, Spackman T. 1975. Chondrodysplasis punctata: is maternal warfarin therapy a factor? Am J Dis Child 129(3): 356-359.
3. Binder KH. 1962. Dysostosis maxillo-nasalis, ein arhinencephaler Missbildungskomplex. Deutsch Zahnaerztl DZZ 17: 438-444.
4. Brunetti-Pierri N, Andreucci MV, Tuzzi R, et al. 2003. X-linked recessive chondrodysplasia punctata: spectrum of arylsulfatase E gene mutations and expanded clinical variability. Am J Med Genet A 117A(2): 164-168.
5. Cancela L, Hsieh CL, Francke U, Price PA. 1990. Molecular structure, chromosome assignment, and promoter organization of the human matrix Gla protein gene. JBiolChem 265(25):15040-15048.
6. Cook K, Prefumo F, Presti F, Homfray T, Campbell S. 2000. The prenatal diagnosis of Binder syndrome before 24 weeks of gestation: case report. Ultrasound Obstet Gynecol 16: 578-581.
7. Cormode EJ, Dawson M, Lowry RB. 1986. Keutel syndrome: clinical report and literature review. Am J Med Genet 24: 289-294.
8. Cuillier F, Cartault F, Lemaire P, Alessandri JL. 2005. Maxillo-nasal dysplasia(binder syndrome): antenatal discovery and implications. Fetal Diagn Ther 20(4): 301-305.
9. Delaire J, Tessier P, Tulasne JF, Resche F. 1980. Clinical and radiologic aspects of maxillonasal dysostosis(Binder syndrome). Head Neck Surg 3(2): 105-122.
10. Eash DD, Weaver DD, Brunetti-Pierri N. 2003. Cervical spine stenosis and possible vitamin K deficiency embryopathy in an unusual case of chondrodysplasia punctata and an updated classification system. Am J Med Genet A 122A(1): 70-75.
11. Elçioglu N, Hall CM. 1998. Maternal systemic lupus erythematosus and chondrodysplasia punctata in two sibs: phenocopy or coincidence? J Med Genet35(8): 690-694.
12. Franco B, Meroni G, Parenti G, et al. 1995. A cluster of sulfatase genes on Xp22.3: mutations in chondrodysplasia punctata(CDPX) and implications for warfarin embryopathy. Cell 81(1): 15-25.
13. Garnier A, Dauger S, Eurin D, et al. 2007. Brachytelephalangic chondrodysplasia punctata with severe spinal cord compression: report of four new cases. Eur JPediatr 166(4): 327-331.
14. Gross-Kieselstein E, Har-Even Y, Navon P, Branski D. 1986. Familial variant of maxillonasal dysplasia? J Craniofac Genet Dev Biol 6: 331-334.
15. Hall JG, Pauli RM, Wilson KM. 1980. Maternal and fetal sequelae of anticoagulation during pregnancy. Am J Med 68(1): 122-140.
16. Horswell BB, Holmes AD, Barnett JS, Levant BA. 1987. Maxillonasal dysplasia(Binder's syndrome): a critical review and case study. J Oral Maxillofac Surg 45(2): 114-122.
17. Howe AM, Lipson AH, de Silva M, Ouvrier R, Webster WS. 1997. Severe cervical dysplasia and nasal cartilage calcification following prenatal warfarin exposure. Am J Med Genet 71(4):391 -396.
18. Kau CH, Hunter LM, Hingston EJ. 2007. A different look: 3-dimensional facial imaging of a child with Binder syndrome. Am J Orthod Dentofacial Orthop 132(5): 704-709.
19. Kelly TE, Alford BA, Greer KM. 1999. Chondrodysplasia punctata stemming from maternal lupus erythematosus. Am J Med Genet 83(5): 397-401.
20. Kerber IJ, Warr OS 3rd, Richardson C. 1968. Pregnancy in a patient with a prosthetic mitral valve. Associated with a fetal anomaly attributed to warfarin sodium. JAMA 203(3): 223-225.
21. Keutel J, Jorgensen G, Gabriel P. 1972. A new autosomal recessive syndrome: peripheral pulmonary stenoses, brachytelephalangism, neural hearing loss and abnormal cartilage calcifications- ossification. Birth Defects Orig Artic Ser VIII(5): 60-68.
22. Khau Van Kien P, Nivelon-Chevallier A, Spagnolo G, Douvier S, Maingueneau C. 1998. Vitamin K deficiency embryopathy. Am J Med Genet 79(1): 66-68.
23. Khosroshahi HE, Uluoglu O, Olgunturk R, Basaklar C. 1989. Keutel syndrome: a report of four cases. Eur J Pediatr 149: 188-191.
24. Leicher-Düber A, Schumacher R, Spranger J. 1990. Stippled epiphyses in fetal alcohol syndrome. Pediatr Radiol 20(5): 369-370.
25. Maroteaux P. 1989. Brachytelephalangic chondrodysplasia punctata: a possible X-linked recessive form. Hum Genet 82: 167-170.
26. Menger H, Lin AE, Toriello HV, Bernert G, Spranger JW. 1997. Vitamin K deficiency embryopathy: a phenocopy of the warfarin embryopathy due to a disorder of embryonic vitamin K metabolism. Am J Med Genet 72(2): 129-134.
27. Munroe PB, Olgunturk RO, Fryns J-P, et al. 1999. Mutations in the gene encoding the human matrix Gla protein cause Keutel syndrome. Nat Genet 21: 142-144.
28. Olow-Nordenram MAK, Radberg CT. 1984. Maxillo-nasal dysplasia(Binder syndrome) and associated malformations of the cervical spine. Acta Radiol 25: 353-360.
29. Olow-Nordenram M, Valentin J. 1988. An etiologic study of maxillonasal dysplasia: Binder's syndrome. Scand J Dent Res 96: 69-74.
30. Pati S, Helmbrecht GD. 1994. Congenital schizencephaly associated with in utero warfarin exposure. Reprod Toxicol 8(2): 115-120.
31. Pettifor JM, Benson R. 1975. Congenital malformations associated with the administration of oral anticoagulants during pregnancy. J Pediatr 86(3): 459-462.
32. Quarrell OWJ, Koch M, Hughes HE. 1990. Maxillonasal dysplasia(Binder's syndrome). J Med Genet 27: 384-387.
33. Resche F, Tessier P, Delaire J, Tulasne JF. 1980. Craniospinal and cervicospinal malformations associated with maxillonasal dysostosis(Binder syndrome). Head Neck Surg 3(2): 123-131.
34. Rotten D, Levaillant JM. 2004. Two- and three-dimensional sonographic assessment of the fetal face. 1. A systematic analysis of the normal face. Ultrasound Obstet Gynecol 23(3): 224-231.
35. Roy-Doray B, Geraudel A, Alembik Y, Stoll C. 1997. Binder syndrome in a mother and her son. Genet Couns 8: 227-233.
36. Sarda P, Guillaumont S, Jalaguier J, Bonnet H. 1989. Conradi H: unermann chondrodysplasia punctata and fetal alcoholism. J Genet Hum 37(4-5): 395-399.
37. Schivazappa L, Rinaldo M, Grella P, Russo R, Bortolotti U. 1982. Fetal malformations caused by oral anticoagulants during pregnancy. Report of a case. G Ital Cardiol 12(12): 897-900.
38. Shaul WL, Emery H, Hall JG. 1975. Chondrodysplasia punctata and maternal warfarin use during pregnancy. Am J Dis Child 129(3):360-362.
39. Sheffield LJ, Danks DM, Mayne V, Hutchinson AL. 1976. Chon- drodysplasia punctata-23 cases of a mild and relatively common variety. JPediatr 89(6): 916-923.
40. Sheffield LJ, Halliday JL, Jensen F. 1991. Maxillonasal dysplasia(Binder's syndrome) and chondrodysplasia punctata. J Med Genet 28(7): 503-504.
41. Trask AS, Gosselin RC, Diaz JA, Dager WE. 2004. Warfarin initiation and monitoring with clotting factors II, VII, and X. Ann Pharmacother 38(2): 251 -256.
42. Yasuda S, Koike T. 2006. New insights into the pathogenicity of antiphospholipid antibodies. Nihon Rinsho Meneki Gakkai Kaishi 29(5): 311-318.